Audit Reveals Transparency Gaps in Pet Supplements
A market audit has found that more than 99% of reviewed pet supplement entries lacked published clinical trials on their finished products. Additionally, 92% omitted public lab test results, and 61% failed to disclose individual active ingredient amounts. Published by pet supplement maker La Petite Labs, the report underscored significant gaps in consumer-facing transparency across the industry. Read the full Pet Supplement Brand Transparency Report.
Roo Launches Free CE Platform
Veterinary staffing platform Roo has launched a free continuing education and career development service for the veterinary industry. Available to veterinarians, technicians, practice managers, and students, the platform offers on-demand courses, live webinars, and expert-led events. It features RACE-approved content and a built-in CE tracker. According to the company, the initiative aims to make professional development accessible without paid memberships, regardless of whether users work with Roo.
IDEXX Launches First Dual-Species In-Clinic Cardiac Test
IDEXX Laboratories has introduced the Catalyst proBNP Test, the first point-of-care NT-proBNP test for both cats and dogs. Delivering quantitative results in minutes during patient visits, the biomarker test helps veterinarians evaluate heart disease without waiting for external lab results or immediate referrals. Available on the Catalyst platform, it integrates with routine chemistry workflows to enable earlier diagnosis and treatment. The test launches in North America in October 2026.
Hill’s and HABRI Partner to Advance Human-Animal Bond Research
Hill’s Pet Nutrition has partnered with the Human Animal Bond Research Institute (HABRI) to support and expand research on the health benefits of the human-animal bond. The collaboration aims to scientifically document how companion animals enhance human physical, mental, and social well-being. According to HABRI, understanding and leveraging this bond also encourages better pet care behaviors, including improved nutrition and more frequent veterinary visits.
Gamgee Secures $4M to Pioneer Personalized Canine Cancer Vaccines
Gamgee has launched with a $4 million seed round led by Founders Fund to develop personalized canine cancer treatments. The biotech startup leverages genomics, AI, and mRNA technology to create patient-specific vaccines that train the immune system to attack tumor-specific neoantigens. Gamgee is currently conducting clinical studies in Australia in collaboration with veterinary oncologists and leading research institutions.
Hill’s Announces Leadership Appointments
Hill’s Pet Nutrition has announced three strategic executive appointments to drive global growth and workplace innovation. Wendy Boise has been named executive vice president, people, bringing 26 years of HR experience. Keith Wilkinson was promoted to senior vice president, global customer development, to expand international partnerships. Additionally, Carolyn Belloni joins the company to succeed Wilkinson as senior vice president, customer development, Hill’s U.S.